Since the release of ICH E6(R2), multiple efforts have been made to interpret the requirements and suggest ways of implementing quality tolerance limits (QTLs) alongside existing risk-based quality management methodologies.
Since the release of ICH E6(R2), multiple efforts have been made to interpret the requirements and suggest ways of implementing quality tolerance limits (QTLs) alongside existing risk-based quality management methodologies.
CluePoints is dedicated to revolutionizing clinical trials through AI, advanced statistics, and machine learning. Aligned with global regulatory guidance, our holistic risk-based approach is designed to drive positive outcomes. Ready to uncover the clues and pinpoint success in your next trial? Contact our expert team today.
